Microenvironmental regulation of tumor progression and metastasis
By D. Quail, J. Joyce. Nature Medicine, 2013
7,271 citations recorded by the source corpus.
Cancers develop in complex tissue environments, which they depend on for sustained growth, invasion and metastasis. Unlike tumor cells, stromal cell types within the tumor microenvironment (TME) are genetically stable and thus represent an attractive therapeutic target with reduced risk of resistance and tumor recurrence. However, specifically disrupting the pro-tumorigenic TME is a challenging undertaking, as the TME has diverse capacities to induce both beneficial and adverse consequences for tumorigenesis. Furthermore, many studies have shown that the microenvironment is capable of normalizing tumor cells, suggesting that re-education of stromal cells, rather than targeted ablation per se, may be an effective strategy for treating cancer. Here we discuss the paradoxical roles of the TME during specific stages of cancer progression and metastasis, as well as recent therapeutic attempts to re-educate stromal cells within the TME to have anti-tumorigenic effects.
Subfields: Biotechnology, Cancer Research, Oncology
View Paper: https://www.semanticscholar.org/paper/0da9a092ae16f77da86abcde9526393773d94c0f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biotechnology
- R. Weinberg
- Lisa M. Coussens
- Zena Werb
- J. Pollard
- D. Pattabiraman
- Arthur W. Lambert
- J. Cubillos-Ruiz
- Laurie H. Glimcher
In Cancer Research
In Oncology
Citations in the corpus
- Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy (2018, positive): “The TME comprises extracellular matrix and a combination of stromal and immune cells, all of which impact disease progression and clinical outcomes (Quail and Joyce, 2013).”
- Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer (2017, positive): “…RESPONSES IN TUMOR-ASSOCIATED IMMUNE CELLS The microenvironment of most established tumors is formed by stromal cells including leukocytes, vascular cells and fibroblasts, whose normal functions are actively co-opted by cancer cells in order to promote malignant progression (Quail and Joyce, 2013).”
- Roles of the immune system in cancer: from tumor initiation to metastatic progression (2018, background): “…intratumor heterogeneity: Genomic instability (McGranahan and Swanton 2015), hierarchical organization arising from initiating cancer stem cells (Kreso and Dick 2014), and selective pressure imposed by the immune system likely impact antigen heterogeneity of the tumor (Quail and Joyce 2013).”
- EMERGING BIOLOGICAL PRINCIPLES OF METASTASIS (2017, positive): “Metastatic colonization is also likely to be impacted by cells of both the innate and adaptive immune system (Kitamura et al., 2015; Quail and Joyce, 2013).”
- The tumor microenvironment underlies acquired resistance to CSF1R inhibition in gliomas (2016, background): “Given that TME-targeted agents are increasingly being evaluated in the clinic (1, 2), it will be critical to mechanistically define how resistance evolves in response to these therapies in order to provide long-term disease management for patients.”
- A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer (2019, background): “uPAR is generally connected with tumor dormancy, EGFR is activated by uPAR (ligand-independent mode), sustaining cell proliferation via a mechanism where fibronectin/αvβI integrin and ERK are stimulated [68,76], finally leading to an increased metastatic rate in RAS-mutated tumors [76].”